Archive for the ‘biotech/medical’ category: Page 1778
Jan 20, 2020
Iceye releases dark vessel detection product
Posted by Genevieve Klien in categories: biotech/medical, government, information science, robotics/AI, satellites
SAN FRANCISCO – Radar satellite operator Iceye released a product Jan. 20 to detect dark vessels, ships at sea that are not identifying themselves with Automatic Identification System (AIS) transponders.
Iceye combines observations from its constellation of three synthetic aperture radar satellites with other data sources to provide customers with radar satellite images of vessels that are not broadcasting their identification, position and course with AIS transponders. The technology is designed to help government agencies, nongovernmental organizations and commercial customers curb drug and human trafficking, find illegal fishing vessels and enforce rules against illegal transshipment of goods, Finland-based Iceye said in a Jan. 20 news release.
Dark vessel detection is a popular application for radar satellites which gather data day, night and in all weather conditions, Pekka Laurila, Iceye co-founder and chief strategy officer told SpaceNews. With three satellites in orbit, Iceye offers customers the ability to frequently revisit areas of interest. In addition, the company has developed machine learning algorithms to speed up dark vessel detection, he added.
Jan 20, 2020
Belgian neurologist wins €1m prize for work on serious brain trauma
Posted by Quinn Sena in categories: biotech/medical, neuroscience
Generet prize will fund more trials by Steven Laureys to help written-off ‘vegetative’ patients.
Jan 20, 2020
Human fetal lungs harbor a microbiome signature
Posted by Xavier Rosseel in category: biotech/medical
The lungs and placentas of fetuses in the womb — as young as 11 weeks after conception — already show a bacterial microbiome signature, which suggests that bacteria may colonize the lungs well before birth. This first-time finding deepens the mystery of how the microbes or microbial products reach those organs before birth and what role they play in normal lung and immune system development.
A team led by University of Alabama at Birmingham researcher Charitharth Vivek Lal, M.D., found that a human fetal microbiome DNA signature is present in lungs as early as the first trimester. This fetal lung microbiome showed changes in diversity during fetal development, suggesting microbiome maturation with advancing gestational age. Finally, a placental microbiome was also present in human fetal tissue, and this microbiome signature showed some taxonomic overlap with the corresponding human fetal lung microbiome.
“We speculate that maternal-fetal microbial DNA transfer — and perhaps of other microbial products and whole live or dead bacteria — is a realistic possibility,” said Lal, an associate professor in the UAB Pediatrics Division of Neonatology. “This may serve to ‘prime’ the developing innate immune system of the fetus and help in establishment of a normal host-commensal relationship.”
Jan 20, 2020
Physics shows that imperfections make perfect
Posted by Xavier Rosseel in category: biotech/medical
Northwestern University researchers have added a new dimension to the importance of diversity.
For the first time, physicists have experimentally demonstrated that certain systems with interacting entities can synchronize only if the entities within the system are different from one another.
This finding offers a new twist to the previous understanding of how collective behavior found in nature—such as fireflies flashing in unison or pacemaker cells working together to generate a heartbeat—can arise even when the individual insects or cells are different.
Jan 20, 2020
3D Bioprinted Organ Just Took Its First “Breath”
Posted by Brent Ellman in categories: 3D printing, bioprinting, biotech/medical
3D bio-printed Lung tissue.
Rice University researcher’s bioprinting method could be scaled up to one day construct an entire organ and allow organs to be made using some of a patient’s own cells to prevent organ rejection. Researcher’s long term goals are to bioprint fully functioning organs. Synthetic organs can extend the waiting period of an average 3.6 years for a real organ.
Continue reading “3D Bioprinted Organ Just Took Its First ‘Breath’” »
Jan 20, 2020
Immune discovery ‘may treat all cancer’
Posted by Quinn Sena in category: biotech/medical
Research is at an early stage but scientists said it had huge potential for destroying cancers.
Jan 20, 2020
Against All Odds
Posted by Paul Battista in categories: biotech/medical, life extension
Jane McLelland beat cervical, lung, and blood cancers using the missing link to defeat cancer: starving it. She is partnering with Life Extension® to help other patients achieve the same results.
By Laurie Mathena.
Jan 20, 2020
Aubrey de Grey, CSO, SENS, “Scientists, check — Investors, check — Next up, policy makers”
Posted by Paul Battista in categories: biotech/medical, life extension, policy
After getting a considerable success in convincing scientists and investors, in the last decades, that undoing aging through a damage repair approach is possible and desirable, Aubrey de Grey is turning his advocacy efforts to politicians. In this video, he explains why.
https://thelongevityforum.com/
Aubrey de Grey delivers a keynote on the next steps for longevity for policy makers.
Jan 20, 2020
Israel launches its first AI-powered flu vaccination campaign
Posted by Omuterema Akhahenda in categories: biotech/medical, information science, robotics/AI
The company’s machine learning-based tool applies advanced algorithms to Maccabi’s existing electronic patient data to identify unvaccinated individuals at highest risk of developing serious flu-related complications. These could include elderly people; those with uncontrolled chronic diseases or respiratory diseases; long-term smokers; those that are immunodeficient or have diabetes; or children, explained Dr. Jeremy Orr, CEO of EarlySign.
The EarlySign investigational algorithm flags these individuals, who are then contacted by their healthcare providers and encouraged to come into the clinic and be vaccinated. Patients can be contacted by phone, text message or even snail mail, depending on their communication preferences and the methods offered by their clinics.
Orr noted that the program is especially important this year when many people have already died from the flu in Israel and the virus is expected to take an exceptionally heavier toll than usual this year.